Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence study of trimetazidine dihydrochloride modified-release tablets in healthy Thai volunteers under fasting conditions
TCTR20190104001Completed
- Sponsor
- All Research
- Start
- Mar 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of trimetazidine (2 arms), sponsored by All Research. Primary endpoints: Cmax at 48 hours, AUC0-t at 48 hours and 1 more. Started Mar 2019; status: completed.
02
Drugs
trimetazidine
Beyond the preview
Go deeper on TCTR20190104001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20190104001.